Cencora, Inc. (NYSE:COR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Cencora, Inc. (NYSE:COR) has earned an average rating of “Moderate Buy” from the fifteen analysts that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $367.75.

Several research analysts have recently weighed in on the company. Morgan Stanley set a $342.00 price target on Cencora in a research note on Friday, May 8th. Wells Fargo & Company cut their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. UBS Group raised their price objective on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Weiss Ratings downgraded shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Finally, Barclays cut their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th.

Cencora Stock Down 1.4%

COR stock opened at $282.04 on Tuesday. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The company has a market capitalization of $54.87 billion, a price-to-earnings ratio of 21.63, a PEG ratio of 1.59 and a beta of 0.59. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The stock has a fifty day moving average of $280.03 and a 200-day moving average of $321.68.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts predict that Cencora will post 17.79 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.

Cencora announced that its Board of Directors has initiated a share repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

Insider Transactions at Cencora

In related news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.38% of the company’s stock.

Institutional Trading of Cencora

A number of institutional investors have recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. bought a new position in Cencora in the 4th quarter worth about $25,000. Oakworth Capital Inc. bought a new position in Cencora in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new position in Cencora in the 4th quarter worth about $27,000. Archer Investment Corp increased its stake in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new position in Cencora in the 4th quarter worth about $29,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.